Literature DB >> 12573690

Day treatment for cocaine dependence: incremental utility over outpatient counseling and voucher incentives.

Douglas B Marlowe1, Kimberly C Kirby, David S Festinger, Elizabeth P Merikle, Giao Q Tran, Jerome J Platt.   

Abstract

Urban, poor, crack cocaine-dependent clients were randomly assigned to outpatient addiction counseling (n=39) or day treatment (n=40). Participants in both conditions received equivalent individual cognitive-behavioral counseling and earned equivalent payment vouchers for providing cocaine-negative urine samples. However, day treatment participants attended significantly more psychoeducational and recreational groups and received two meals per day. Prior to random assignment, more participants expressed a preference for day treatment and participants were more likely to return for an initial appointment following assignment to day treatment. However, no significant between-groups differences in tenure or abstinence were detected during the 3-month course of treatment. These null findings were attributable to an absence of a dose-response effect for the group interventions in the day treatment condition. In addition, there may have been a ceiling effect from the vouchers, which masked the influence of the additional day treatment components.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12573690     DOI: 10.1016/s0306-4603(01)00248-9

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  2 in total

Review 1.  Individually randomized group treatment trials: a critical appraisal of frequently used design and analytic approaches.

Authors:  Sherri L Pals; David M Murray; Catherine M Alfano; William R Shadish; Peter J Hannan; William L Baker
Journal:  Am J Public Health       Date:  2008-06-12       Impact factor: 9.308

Review 2.  Patient Preferences and Shared Decision Making in the Treatment of Substance Use Disorders: A Systematic Review of the Literature.

Authors:  Anke Friedrichs; Maren Spies; Martin Härter; Angela Buchholz
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.